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Etiology of nephrocalcinosis in preterm neonates: Association Nephrocalcinosis (NC) occurs frequently in preterm
of nutritional intake and urinary parameters. neonates. The incidence varies between 17 and 64%, de-
Background. Nephrocalcinosis (NC) in preterm neonates pending on different study populations, ultrasonographichas been described frequently, and small-scale studies suggest
(US) criteria, and US equipment [1–6]. Short-term com-an unfavorable effect on renal function. The etiologic factors
have not yet been fully clarified. We performed a prospective plications include nephrolithiasis with obstruction of the
observational study to identify factors that influence the devel- urinary tract and urinary tract infection [2]. The long-
opment of NC. term outcome of NC in preterm neonates has not beenMethods. The study population consisted of 215 preterm
defined, but small-scale studies suggest a decrease inneonates with a gestational age ,32 weeks. Clinical characteris-
tics and intake in the first four weeks of calcium, phosphorus, renal function [7–9].
vitamin D, protein, and ascorbic acid were noted. Serum cal- The etiology of NC in preterm neonates has not yet
cium, phosphate, vitamin D, magnesium, uric acid, creatinine, been fully clarified. Furosemide therapy, because of itsurea and urinary calcium, phosphate, oxalate, citrate, magne-
hypercalciuric effect, is most frequently mentioned as asium, uric acid, and creatinine were assessed at four weeks of
age and at term. Renal ultrasonography (US) was performed provoking factor [1, 2, 6, 10]. Treatment with corticoste-
at four weeks and at term. At term was defined as a postconcep- roids and xanthines may also contribute to stone forma-
tional age of 38 to 42 weeks. tion [11, 12], and neonates with a lower birth weight andResults. NC was diagnosed by means of US in 33% at four
a shorter gestational age appear to run a higher risk ofweeks and in 41% at term. Patients with NC at four weeks
had a significantly higher mean intake of calcium (P , 0.05), developing NC [1, 3, 6, 11]. In adults with stone forma-
phosphorus (P , 0.05), and ascorbic acid (P , 0.01) than tion, various abnormalities have been identified that
patients without NC. They had a higher mean serum calcium might explain the increased supersaturation and nucle-(2.55 vs. 2.46 mmol/L, P , 0.01) and a higher mean urinary
ation, growth, and agglomeration of crystals. These in-calcium/creatinine ratio (2.6 vs. 2.1 mmol/mmol, P , 0.05).
Patients with NC at term had a lower birth weight (1142 vs. clude hypercalciuria induced by various causes, hyperox-
1260 g, P , 0.05) and a lower gestational age (28.8 vs. 29.4 aluria, and hypocitraturia [13]. These abnormalities
weeks, P , 0.05), were treated significantly longer with furose- might also play a role in preterm neonates, as has beenmide, dexamethasone, theophylline, and thiazides, developed
suggested by others [3, 14–16]. Moreover, preterm neo-chronic lung disease more frequently (40 vs. 16%, P , 0.001),
and had a higher mean urinary calcium/creatinine ratio (2.7 nates receive a high intake of calcium, phosphorus, and
vs. 2.3 mmol/mmol, P , 0.05) and a lower mean urinary citrate/ vitamin D in the first months of life in order to prevent
calcium ratio (1.1 vs. 1.7 mmol/mmol, P 5 0.005). rickets of prematurity. In a prospective study, we exam-Conclusions. NC develops as a result of an imbalance be-
ined the association of stone-promoting and stone-inhib-tween stone-inhibiting and stone-promoting factors. A high
intake of calcium, phosphorus, and ascorbic acid, a low urinary iting factors with the development of NC in preterm
citrate/calcium ratio, a high urinary calcium/creatinine ratio, neonates.
immaturity, and medication to prevent or treat chronic lung
disease with hypercalciuric side effects appear to contribute to
the high incidence of NC in preterm neonates. METHODS
PatientsKey words: calcium, phosphorus, ascorbic acid, citrate, oxalate, kidney
development, renal stones in neonates. In a prospective study, preterm neonates with a gesta-
tional age ,32 weeks were investigated. All patientsReceived for publication January 11, 2000
were admitted in the first week of life to Leiden Univer-and in revised form May 25, 2000
Accepted for publication June 1, 2000 sity Medical Center or Juliana Children’s Hospital be-
tween May 1996 and November 1998. Patients from out-Ó 2000 by the International Society of Nephrology
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side of the usual referral region of these hospitals were of 40 weeks. It was not feasible to monitor the daily
intake of calcium, phosphorus, ascorbic acid, and vitaminexcluded from the study because of logistic problems.
Informed consent was obtained after oral and written D of every neonate until term, since clinical observation
was no longer necessary in most cases.information had been given. The ethics committees of the
two participating hospitals approved the study protocol.
Biochemical methodsTwo hundred fifteen (67%) of 322 admitted neonates
participated in the study. The reasons for not participat- Blood and urine samples were collected at four weeks
and at term. Urine aliquots were collected in attached plas-ing were refusal of parents to participate in the study
(N 5 27), language barrier (N 5 12), death (N 5 37), tic bags. Immediately after voiding, urine samples were
preserved with thymol or were frozen at 2208C. The pHand miscellaneous (N 5 31). The mean gestational age
and birth weight for the participating and the nonpartici- of samples for oxalate determinations was adjusted to
pH 2 before the samples were frozen. At four weeks,pating groups were not significantly different.
creatinine, urea, calcium, phosphate, vitamin 1,25(OH)2D3,
Study design magnesium, and uric acid were assessed in serum. Creati-
nine, calcium, phosphate, magnesium, oxalate, citrate,Patients were studied at four weeks and at term. At
term was defined as a postconceptional age of 38 to 42 and uric acid were measured in urine. At term, creatinine
was assessed in serum, and creatinine, calcium, oxalate,weeks. At the age of four weeks, 150 patients were stud-
ied; 65 patients could not be studied because they were and citrate were assessed in urine.
Calcium, phosphate, creatinine, urea, citrate, and urictransferred to the referring hospital before the age of
four weeks or because the neonatologist considered them acid were measured with a Hitachi analyzer (Roche diag-
nostics, Almere, The Netherlands). Citric acid was con-too ill for US examination. Two hundred one patients
were studied at term; 14 could not be studied for various verted to oxaloacetate and acetate by citrate lyase. Oxa-
loacetate was then converted to lactate in the presence ofreasons.
l-malate dehydrogenase, l-lactate dehydrogenase, and
Clinical characteristics nicotinamide adenine dinucleotide (NADH). The oxida-
tion of NADH was measured at 340 nm and was stoichio-Gestational age, birth weight, intake of nutrients, med-
ication, urine production, occurrence of acidosis, and metric to the amount of citrate (reference value, 1.6 to
4.8 mmol/L or 3.2 to 9.5 mmol/24 hours). Uric acid wasneed for artificial ventilation and oxygen therapy of pa-
tients with and without NC at the age of four weeks measured using the uricase method. Oxalate was precipi-
tated by calcium sulfate and ethanol. The precipitate iswere compared.
In the first 28 days, the mean intakes per kilogram redissolved, and the oxalate was oxidized to hydrogen
peroxide by oxalate oxidase. The hydrogen peroxide re-per day of calcium, phosphorus, protein, vitamin D, and
ascorbic acid were calculated, using known concentra- acts with 3-methyl-2-benzothiazolinone hydrazone and
diethylamine in the presence of peroxidase to yield antions in formula and parenteral feeding (Nutricia, Zoet-
ermeer, The Netherlands) and breastfeeding [17]. The indamine dye with a maximum absorbance at 590 nm
(method from Instruchemie, Hilversum, The Nether-volume of total intake and volume and number of days
of parenteral feeding, formula, and breastfeeding were lands; reference values ,0.55 mmol/24 hours). Magne-
sium was assessed by atomic absorption spectrophotom-noted separately. In order to find out whether the higher
intake of components was caused by a higher volume of etry. Vitamin 1,25(OH)2D3 was extracted with acetonitril,
purified on a Bondelutt C18OH column (Varian, Harbortotal intake, the “relative intake” was calculated as the
ratio of intake of components (in mmol or mg) and vol- City, USA) and assessed by means of a radio receptor
assay (Incstar, distributed by MP products, Amersfoort,ume of total intake (in mL).
The following clinical data were recorded during the The Netherlands).
When available, we compared our data with valuesfirst 28 days: days of ventilation and days of oxygen
therapy; days of furosemide, thiazide, theophylline, caf- from literature for full-term neonates [19, 20].
feine, and corticosteroid therapy; days with oliguria (,1
UltrasonographymL/kg/hour); mean urine volume (mL/kg/day); mean se-
rum pH per day; and days with a pH ,7.3. Ultrasonography of the kidneys was used to detect NC.
Two pediatric radiologists, one in each center, performedGestational age, birth weight, medication, and pres-
ence of chronic lung disease (CLD) of patients with and the US examinations using state of the art equipment
with a 7 to 7.5 MHz small-part transducer (Toshiba,without NC at term were compared. CLD was defined
as need for oxygen and corresponding abnormalities on Zoetermeer, The Netherlands). Transverse and longitu-
dinal images were made of both kidneys. The radiologiststhe X-thorax at age 36 weeks postconception [18]. Days
of furosemide, thiazide, theophylline, and corticosteroid were not informed about the treatment and medication
of the patients. US was performed at the age of fourtherapy were documented until the postconceptional age
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Table 1. Patient characteristics of the nephrocalcinosis group (NC1) and the non-nephrocalcinosis group (NC2)
4 weeks after birth and at term
Week 4 At term
NC1 NC2 NC1 NC2
Patient characteristics (N550) (N5100) P value (N583) (N5118) P value
Birth weight g 1138 (293) 1163 (342) NS 1142 (353) 1260 (333) ,0.05
Gestational age weeks 28.8 (1.9) 28.7 (2.1) NS 28.8 (2.1) 29.4 (1.9) ,0.05
Furosemide N of treated patients (%) 6 (12) 15 (15) NS 32 (39) 18 (15) ,0.001
Thiazides N of treated patients (%) 3 (6) 7 (7) NS 33 (40) 12 (10) ,0.001
Theophylline N of treated patients (%) 4 (8) 17 (17) NS 33 (40) 17 (14) ,0.001
Corticosteroids N of treated patients (%) 17 (34) 27 (27) NS 31 (37) 22 (19) 0.05
CLD N (%) 33 (40) 19 (16) ,0.001
Values are given as the mean (standard deviation), unless otherwise indicated [N (%)]. Abbreviations are: At term, 38–42 weeks post-conception; NC, nephrocal-
cinosis; CLD, chronic lung disease; NS, not significant.
weeks and at term. NC was defined as the presence
of bright reflections in the medulla or cortex that was
reproducible both in transverse and longitudinal direc-
tions with or without acoustic shadowing. The reflections
varied from small flecks of 1 to 2 mm, white dots larger
than 2 mm, to completely echodense pyramids. Two tiny
echogenic parallel stripes were considered to be the arcu-
ate or branch arteries.
Statistics
Groups were compared using the Student’s t-test for
normally distributed data and the Mann-Whitney test
otherwise. Proportions were compared using a chi-
square test. Repeated measurement analysis of variance
was performed to compare the absolute and the “rela-
tive” intakes of calcium, phosphorus, protein, vitamin
D, and ascorbic acid during the first four weeks between
the NC and non-NC group (SPSS).
RESULTS
Nephrocalcinosis was diagnosed by means of US in
50 out of 150 patients (33%) four weeks after birth and Fig. 1. The mean intake of calcium in the first four weeks in the nephro-
calcinosis (NC) group (NC1; solid line; mean 6 1.96 3 SE) is signifi-in 83 out of 201 patients (41%) at term. Table 1 shows
cantly higher than in the non-NC group (NC–; dashed line; mean 6the patient characteristics of the NC group and the non- 1.96 3 SE) four weeks after birth. Repeated measurement for analysis
NC group at four weeks and at term. At term, the NC of variance was P , 0.05. SE is standard error of the mean.
group had a lower gestational age and birth weight com-
pared with the non-NC group (P , 0.05).
The mean intake of calcium (mmol/kg/day) and phos-
that this significance persisted, which indicates that thephorus (mmol/kg/day) during the first four weeks was
difference in intake between groups cannot be explainedhigher in the NC group compared with the non-NC group
by the difference in intake volume alone. Mean intakes(Figs. 1 and 2). The intake of ascorbic acid was also
of vitamin D and protein were similar in the two groups,higher in the NC group compared with the non-NC
increasing from 1.8 6 0.09 (6 SE) mg/kg/day and 1.3 6group, increasing from 8.3 mg/kg/day at week 1 to 24.0
0.04 g/kg/day in the first week to 12.3 6 0.86 mg/kg/dayat week 4 in the NC group compared with 8.0 and 21.6
and 3.3 6 0.04 g/kg/day, respectively, in the fourth week.mg/kg/day, respectively, in the non-NC group (P , 0.01).
No significant difference was found in days or volumeThe interaction of the group and time effects was signifi-
of parenteral, formula, and breastfeeding.cant, which means that the difference in intake between
Furosemide was not prescribed very often in the firstNC and non-NC changed significantly during the study.
The same analysis for the “relative” intakes revealed four weeks (Table 1). Furosemide treatment did not
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Compared with values from the literature for full-term
neonates, our total population of preterm neonates had
a high urinary calcium/creatinine ratio (UCa/Cr) and a high
urinary oxalate/creatinine ratio (UOx/Cr), both at the age
of four weeks (Fig. 3 and 4) and at term [19, 20].
DISCUSSION
Nephrocalcinosis is a frequently occurring phenome-
non in preterm neonates. This study demonstrates vari-
ous factors that contribute to the development of NC in
preterm neonates, and we subscribe to the multifactorial
etiology [21]. At the age of four weeks, not all infants
could be studied. However, since both extremes in health
status (relatively healthy neonates that could be trans-
ferred to the referring hospital before the age of four
weeks and neonates that the neonatologist considered
too ill for US examination) did not participate in this
part of the study, we presume that this did not influence
the results. At term, such a selection did not take place.
The patients with NC at term had a lower gestational
age and a lower birth weight than the patients without
NC, comparable to other studies [1, 3, 6, 11]. The highFig. 2. The mean intake of phosphorus in the first four weeks in the
NC group (NC1; solid line; mean 6 1.96 3 SE) is significantly higher incidence of NC in preterm neonates as well as this
than in the non-NC group (NC2 dashed line; mean 6 1.96 3 SE) four difference in birth weight and gestational age suggests
weeks after birth. Repeated measurement for analysis of variance was
that crystallization in immature kidneys is common. ThisP , 0.05. SE is standard error of the mean.
can be explained by the following two theories. First,
because the nephron is still developing, heterogeneous
nucleation could occur earlier in preterm neonates thandiffer significantly between the two groups, neither in
in adults. The development of the kidney is centrifugal.the number of treated patients nor in the duration of
First, the deep, medullary nephrons develop and then thetherapy. Also, no differences were found in the adminis-
superficial cortical nephrons [22]. In the tubules, calcium-tration of thiazides, corticosteroids, caffeine, and theoph-
phosphate particles form and dissolve again and can actylline in the first four weeks. However, at term, signifi-
as heterogeneous nucleators for calcium-oxalate crystals.cantly more patients in the group with NC were treated
Early in the loop of Henle, nucleation of crystals canwith furosemide, thiazide, corticosteroids, and theophyl-
occur. In juxtamedullary nephrons, which have a longerline than in the group without NC. Furthermore, the
loop of Henle, a lower plasma oxalate concentration isadministration of furosemide, thiazides, corticosteroids,
required for calcium-oxalate crystal formation than inand theophylline in mean days until week 40 postconcep-
the superficial nephrons [23]. In preterm neonates, oftional age was significantly longer for the at term group
whom the deep nephrons are better developed than thewith NC.
superficial nephrons, heterogeneous nucleation couldThe number of days of artificial ventilation and oxygen
therefore occur earlier than in adults. Second, pretermtherapy in the first four weeks did not differ significantly
neonates have a low glomerular filtration rate (GFR)between the two groups, nor did the number of days
compared with full-term neonates [24], which might leadwith serum pH ,7.3, the mean serum pH, the mean
to a low urine flow velocity. This condition favors theurine volume, or the days with oliguria in the first four
formation of crystals, which then stick to the surface,weeks. Significantly more patients with NC at term devel-
agglomerate, and grow in the tubules [25].oped CLD (Table 1).
Approximately 80% of the calcium and phosphorusTable 2 shows the results of blood and urine studies
accumulate in the fetus between the 25th postconcep-for the NC group and the non-NC group at four weeks
tional week and full term, with a peak between 34 andand at term. Serum phosphate, vitamin 1,25(OH)2D3,
36 weeks [26]. In preterm neonates, therefore, the majormagnesium, uric acid, and urea did not differ statistically
part of bone accumulation takes place ex utero. To pre-between the two groups. Urinary phosphate/creatinine,
vent rickets of prematurity, the recommended intake ofmagnesium/creatinine, oxalate/creatinine, citrate/creati-
calcium, phosphorus, and vitamin D is high comparednine, and uric acid/creatinine ratios did not differ be-
tween the two groups. with full-term neonates. For full-term neonates, the ad-
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Table 2. Serum and urinary values for the nephrocalcinosis group (NC1) and the non-nephrocalcinosis group (NC2)
4 weeks after birth and at term
Week 4 At term
NC1 NC2 NC1 NC2
(N550) (N5100) P value (N583) (N5118) P value
Serum
Calcium mmol/L 2.55 (0.14) 2.46 (0.16) ,0.01
Vitamin 1,25(OH)2D3 pmol/L 158 (59) 138 (57) NS
Creatinine lmol/L 38 (11) 44 (10) ,0.01 28 (8) 30 (7) ,0.05
Urinary
Calcium/creatinine mmol/mmol 2.6 (1.5) 2.1 (1.6) ,0.05 2.7 (2.3) 2.3 (2.8) ,0.05
Citrate/calcium mmol/mmol 0.6 (0.5) 0.7 (0.9) NS 1.1 (1.2) 1.7 (1.4) 0.005
Oxalate/creatinine mmol/mmol 0.4 (0.3) 0.5 (0.2) NS 0.4 (0.2) 0.4 (0.2) NS
Uric acid/creatinine mmol/mmol 1.4 (0.6) 1.3 (0.6) NS
Values are given as the mean (standard deviation). Abbreviations are: At term, 38–42 weeks post-conception; NC, nephrocalcinosis; NS, not significant.
Fig. 3. The urinary calcium/creatinine ratio of 122 preterm neonates Fig. 4. The urinary oxalate/creatinine ratio of 102 preterm neonates
at four weeks compared with reference values [19]. Dashed lines are at four weeks compared with reference values [20]. Dashed lines are
95% values and dotted line denotes the mean of healthy term infants 95% values and dotted line denotes the mean of healthy term infants
aged five days to seven months (mean 5 2.2; SD 5 1.55) [19]. aged two to eight weeks (mean 5 0.43; SD 5 0.23) [20].
vised enteral intake of calcium, phosphorus, and vitamin ence in vitamin D intake between our study groups, but
D is 1.7 mmol/kg/day, 1.1 mmol/kg/day, and 1.2 to 2.9
compared with the advised intake for full-term neonates,
mg/kg/day, respectively [27]. We found that the high in-
the vitamin D intake was high.take of calcium and phosphorus currently administered
High calcium intake can lead to high urinary calciumto preterm neonates in the first four weeks creates a risk
excretion in preterm neonates [26, 29], but, to our knowl-of NC, since our patients with NC had a higher intake of
edge, the effect of calcium intake on the developmentcalcium and phosphorus and serum calcium and UCa/Cr
of NC has not been studied precisely. Saarela studiedwere higher. Compared with values from literature for
calcium intake in preterm neonates at only three pointsfull-term neonates, UCa/Cr for preterm neonates was
in time (weeks 4, 6, and 8) and did not find a significantlyhigher (Fig. 3) [19]. Our values are comparable to values
higher intake for neonates with NC [6]. However, ourfor preterm neonates of Campfield et al [14] and Karlen,
Aperia, and Zetterstrom [28]. We did not find a differ- data, which were acquired by studying the total calcium
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intake in the first four weeks, do show a significant differ- ing schedules are applied to preterm neonates in our
NICUs; in case of hypocalcemia or hypophosphatemia,ence between the group with and the group without NC.
We found a relationship between a high intake of supplementation is started. However, serum calcium and
serum phosphate were not lower in the group that devel-phosphorus and the development of NC, which has been
reported before. In the study of Saarela et al, 26 preterm oped NC. Neither was a difference found in the total in-
take in volume, nor in the type of feeding (days of paren-neonates with NC had a higher intake of phosphorus at
weeks 6 and 8 compared with the 103 neonates without teral, formula, or human milk feeding), which can be
held responsible for the different intakes of various nutri-NC [6]. For patients with X-linked hypophosphatemia,
who were treated with calcitriol and P supplements, sev- ents. We suggest that because of the quickly changing
clinical pattern in neonates, individual differences occur,eral studies [30, 31], but not all [32], have shown a correla-
tion between P intake and the development of NC [31, leading to the different intake of nutrients in both groups.
It should be considered that the absorption of enteral33, 34]. The high P intake of these children can lead to
a Ca and P complex in the intestines, and secondary feeding is lower than that of parenteral feeding. There
are large individual variations in the absorption and re-hyperoxaluria can develop. Since less Ca is available for
oxalate, oxalate will form complexes with sodium. In the tention of calcium and phosphorus; the absorption of
calcium ranges from 35 to 75%, and the retention ofintestines, sodium-oxalate complexes are more readily
absorbed than calcium-oxalate complexes so that the phosphorus varies from 50 to 95% in preterm neonates
[26]. Therefore, the real absorption cannot be calculatedenteral oxalate intake is increased. This leads to hyperox-
aluria and can cause NC, even in a normocalciuric state from our data.
A well-known effect of the administration of furose-[30, 33]. Nonetheless, we did not find a significant differ-
ence in UOx/Cr in the NC group compared with the non- mide is hypercalciuria and NC [14, 38–40]. This study
shows, as other authors have already suggested beforeNC group.
We found a significantly higher intake of ascorbic acid [3, 41, 42], that in the first four weeks of life furosemide
therapy is not the major cause of the development offor the NC group at four weeks. Ascorbic acid is a precur-
sor of oxalate and therefore can play an important role NC in preterm neonates, since only 6 of the 50 patients
with NC at the age of four weeks received furosemidein the formation of calcium-oxalate stones. However, as
mentioned previously in this article, we did not find a (Table 1) [3]. Thus, even without any furosemide treat-
ment, NC develops in a high percentage of preterm neo-significant difference in the UOx/Cr. Hoppe et al compared
full-term infants with preterm infants and found a higher nates. In the following months, until term is reached, we
found a significant difference in the administration ofUOx/Cr for preterm neonates [15]. When we compare the
UOx/Cr of all preterm neonates in our study with the values furosemide, theophylline, dexamethasone, and thiazides.
The patients with NC developed CLD significantly morefor full-term neonates as reported in literature, our re-
sults confirm these findings (Fig. 4) [20]. Thus, although often. Neonates who develop CLD are generally more
immature and often need more of the previously men-we could not demonstrate an intergroup difference, pre-
term neonates in general have a higher oxalate excretion tioned medication. Therefore, our data cannot differenti-
ate between a cause and an effect of these factors.than full-term neonates. Barratt found a significantly
higher UOx/Cr for infants than for older children, and in The hypercalciuric effect of xanthines, for example,
theophylline and caffeine, has been described beforechildren, plasma oxalate was independent of age and the
plasma creatinine level [35]. Thus, the high excretion of [12], and we could confirm this effect in prematures at
term. In accordance with Kamitsuka’s findings [11] andoxalate seems to not be related to a high plasma oxalate,
but perhaps handling of oxalate by the tubules changes findings on infant pigs [43], but inconsistent with the
results of Sonntag and Gaude for preterm neonates [44],with age. However, for preterm neonates, plasma oxalate
values are unknown. In adults, the effect of a high intake we found a stone-promoting effect of dexamethasone.
The protective, inhibiting effect on stone formation ofof ascorbic acid on stone formation is debatable; some
studies found a higher excretion of oxalate after ascorbic thiazides could not be demonstrated in our study [38, 45].
Maybe this effect is small and is overruled by the effectacid supplementation [36], and others did not [37]. Com-
pared with adults (0.75 to 1 mg/kg/day), the preterm of the previously described stone-promoting factors.
In our group, patients who developed NC had a lowerneonates in our study had a relatively high intake of
ascorbic acid. The required dose of ascorbic acid for urinary citrate/calcium ratio (UCitr/Ca), comparable to
adults with stone formation in relationship to controlspreterm neonates is not known exactly.
Although we found a difference in intakes of calcium, [46, 47]. The values we found in our entire study popula-
tion are comparable to the values for preterm neonatesphosphate, and ascorbic acid between the NC group and
the non-NC group, we cannot differentiate from our data that Hoppe et al described [48]. Values for full-term
neonates are not available, but compared with valueswhy patients received different intakes. As in other neo-
natology intensive care units (NICUs), standardized feed- for healthy full-term three- to six-year-old children [49],
Schell-Feith et al: Etiology of NC in preterm neonates2108
the preterm neonates of this study had a low UCitr/Ca, term neonates, but they now appear to be overdoses for
the kidneys. Neonates who develop NC indeed have aindicating that preterm neonates in general run a high
risk of developing NC. It should be mentioned that both higher UCa/Cr. The accompanying high intake of ascorbic
acid might contribute to the high UOx/Cr in preterm neo-groups of data, that is, the study of Miyake et al and
ours, exhibit a very broad distribution. The stone-inhib- nates. To treat CLD, several medications with hypercal-
ciuric side effects are administered that do not influenceiting effect of citrate is caused by two mechanisms. First,
citrate forms a better soluble complex with calcium, and the development of NC in the first month, but are likely
to contribute to this in the period until at term. Finally,thus, calcium cannot bind to oxalate or phosphate to
form a less soluble complex. Second, citrate inhibits the comparable to adults with stone formation, preterm neo-
nates who develop NC have a low UCitr/Ca. We hypothesizecrystallization process of calcium-oxalate crystals [50].
Finally, we found an unexpectedly lower serum creati- that all of these factors contribute to the development
of NC in 40% of the neonates in the first months of life.nine for the NC group than for the non-NC group, both
at the age of four weeks and at term. However, all values
were well within the normal range, and the minimal ACKNOWLEDGMENTS
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literature on NC in preterm neonates, we must take into
account the fact that US is a subjective method and is Reprint requests to Eveline A. Schell-Feith, Kinder en Jeugd Centrum,
J6-S, LUMC, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands.known for its operator-dependent approach. In this
E-mail: E.A.Schell-Feith@lumc.nlstudy, US was used to detect NC because it is a noninva-
sive and sensitive method that does not involve radiation.
Moreover, only two pediatric radiologists, one in each APPENDIX
center, performed all of the US examinations. It has
Conversion ratesbeen confirmed histologically that US is more sensitive
Calcium mmol/kg to mg/kg 3 40than plain x-rays for detecting calcifications in the kidney
Calcium mol/L to mg/dL 3 4[51]. For rabbits with histologically demonstrated NC, Phosphorus mmol/kg to mg/kg 3 31
US was more sensitive than computed tomography (CT; Vitamin D pmol/L to pg/L 3 0.42
Vitamin D mg/kg to IU/kg 3 4096 vs. 64%), but CT was more specific than US (96 vs.
Creatinine mmol/L to mg/dL 3 0.011385%) [52]. CT of the kidneys in preterm neonates is Calcium/creatinine mmol/mmol to mg/mg 3 0.35
considered unsuitable for the detection of NC. Calcium/citrate mmol/mmol to mg/mg 3 0.21
Oxalate/creatinine mmol/mmol to mg/mg 3 0.78Causes, other than NC, of increased medullary echo-
Uric acid/creatinine mmol/mmol to mg/mg 3 1.49genicity in the preterm neonate are renal transient med-
ullary hyperechogenicity, candidiasis, cytomegalovirus
infection, infantile polycystic kidney disease, cortical ne-
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